References
- KedharSRThorneJEWittenbergSDunnJPJabsDAMultifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentationRetina20072791174117918046221
- WatzkeRCPackerAJFolkJCBensonWEBurgessDOberRRPunctate inner choroidopathyAm J Ophthalmol19849855725846208783
- PatelKHBirnbaumADTesslerHHGoldsteinDAPresentation and outcome of patients with punctate inner choroidopathy at a tertiary referral centerRetina20113171387139121478811
- BrownJJrFolkJCReddyCVKimuraAEVisual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal syndromeOphthalmology19961037110011058684800
- FlaxelCJOwensSLMulhollandBSchwartzSDGregorZJThe use of corticosteroids for choroidal neovascularisation in young patientsEye (Lond)199812pt 22662729683952
- SimDAShethHGKainesATufailAPunctate inner choroidopathy-associated choroidal neovascular membranes during pregnancyEye (Lond)200822572572718369374
- WachtlinJHeimannHBehmeTFoersterMHLong-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseasesGraefes Arch Clin Exp Ophthalmol20032411189990614556077
- MenezoVCuthbertsonFDownesSMPositive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathyRetina20103091400140420224465
- CornishKSWilliamsGJGavinMPImrieFRVisual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathyEur J Ophthalmol201121444044521188681
- PostelmansLPasteelsBCoqueletPPhotodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like)Ocul Immunol Inflamm200513536136616419421
- SapersteinDARosenfeldPJBresslerNMVerteporfin in Ocular Histoplasmosis (VOH) Study GroupPhotodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case seriesOphthalmology200210981499150512153802
- NolanAWeidenMDThurstonGGoldJAVascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsisInflammation200428527127816134000
- ChanWMLaiTYLiuDTLamDSIntravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic originAm J Ophthalmol2007143697798317459318
- RouvasAPetrouPDouvaliMIntravitreal ranibizumab for the treatment of inflammatory choroidal neovascularizationRetina201131587187921358461
- MangatSSRamasamyBPrasadSWaltersGMohammedMMckibbinMResolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case seriesSemin Ophthalmol20112611321275596
- FongKCThomasDAminKInzerilloDHorganSEPhotodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathyEye (Lond)200822452853317237756
- ChanWMLaiTYLauTTLeeVYLiuDTLamDSCombined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective seriesRetina2008281718018185141
- Schmidt-ErfurthUSchlötzer-SchrehardUCursiefenCMichelsSBeckendorfANaumannGOInfluence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factorInvest Ophthalmol Vis Sci200344104473448014507895